Key result
Specific serum proteomic peaks predict major cardiovascular events risk in acute coronary syndrome.
Why the study?
Novel biomarkers for prognosis in patients with acute coronary syndrome were needed to improve prediction of major adverse cardiovascular events.
Do specific serum protein peaks predict major adverse cardiovascular events in patients with acute coronary syndrome?
Observational (n=245)
Do specific serum protein peaks predict major adverse cardiovascular events in patients with acute coronary syndrome?
Answers are grounded in this paper and cite their sources.
Novel serum protein peaks identified via mass spectrometry may serve as predictive biomarkers for MACE in patients with acute coronary syndrome.
The aim of this study is to find novel biomarkers for prognosis in patients with acute coronary syndrome (ACS). We enrolled 245 eligible patients with ACS and compared the protein expression between the two groups, with or without major adverse cardiovascular events (MACE). To determine biomarkers for prognosis, we performed mass spectrometry analysis. We found 10 proteins in the serum that can be used to classify ACS with or without MACE and specific protein peaks at m/z 1921.0, 2124.2, and 20887.3 that were increased in patients with MACE. These peaks reliably predict MACE occurrence in patients with ACS, in addition to the widely accepted markers troponin and brain natriuretic peptide precursor. The characteristic changes in the peaks at m/z 1921.09, 2124.2, and 20887.3 correlate with poor prognosis in ACS patients. These proteins could potentially be used as predictive biomarkers to evaluate patient prognosis.
No takes yet. Share an insight, caveat, or question.
Zeng et al. (2010) conducted an observational in Acute Coronary Syndrome (ACS) (n=245). Serum protein biomarkers (peaks at m/z 1921.0, 2124.2, and 20887.3) vs. Lower levels or absence of these specific protein peaks was evaluated on Major adverse cardiovascular events (MACE). Specific serum protein peaks at m/z 1921.0, 2124.2, and 20887.3 reliably predicted the occurrence of major adverse cardiovascular events in patients with acute coronary syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: